HEMISPHERX BIOPHARMA INC·4

Aug 1, 11:59 AM ET

Pascale Adam 4

4 · HEMISPHERX BIOPHARMA INC · Filed Aug 1, 2017

Insider Transaction Report

Form 4
Period: 2017-07-31
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2017-07-31$0.30/sh+6,929$2,0796,929 total
    Exercise: $0.42From: 2017-07-31Exp: 2027-07-31Common Stock (6,929 underlying)
Footnotes (1)
  • [F1]This option is being issued in exchange for a voluntary 20% deduction in salary.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT